Sector Strength in Materials, Weakness in Biotech [View article]
Biotech weakness has to do with DNDN Dendreon Corporation's free fall. That sort of thing causes jittery investors in other firms to follow the herd at times. It isn't necessarily rational.
Sector Strength in Materials, Weakness in Biotech [View article]